Evaluation of efficacy of improved nutrition for patients with head and neck cancer underwent oral nutritional supplements.
- Conditions
- Head and neck cancer
- Registration Number
- JPRN-UMIN000009348
- Lead Sponsor
- Kanazawa Medical University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 30
Not provided
1.Patients who have a history of hypersensitivity to enteral nutritional supplements. 2.Patients with ileus. 3.Patients without an enteric function. 4.Patients with severe liver failure and/or renal failure. 5.Patients with abnormal glucose metabolism such as severe diabetes. 6.Patients with inborn error of amino acid metabolism. 7.Patients who had blood transfusion within one month. 8.Patients with active infection. 9.Patients with severe organ failure. 10.Patients who have edema at the time of registration. 11.Patients with electric implantable devices such as pacemakers. 12.Patients who are pregnant, suspected to be pregnant or breastfeeding. 13.Patients judged to be inappropriate for the study by the investigator.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Rate of change of body weight. Dose of oral nutritional supplements per body weight.
- Secondary Outcome Measures
Name Time Method